Atlas Trials

Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia

Clinical trial NCT01543477 · COMPLETED

Trial details

NCT number
NCT01543477
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Renal AnemiaPregnancyLactation
Start date
2010-07-07
Primary completion
2020-04-29
Enrollment
4501

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.